The impact of drug price controls on innovation, market distortions caused by pharmacy benefit managers (PBMs), and the importance of accelerated approval came up in …
House hearings on 2024 health budget touch on price controls and PBMs Read More »
The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade associations convened by BIO, joined forces in Washington DC on Tuesday and …
CSBA hits Capitol Hill for face time with lawmakers Read More »
Legislation that has been reintroduced in the Senate and has the support of the Biotechnology Innovation Organization (BIO) is set to enhance research, an essential …
R&D in biotech gets a boost with reintroduced bill Read More »
The Department of Health and Human Services (HHS) and Department of Commerce (DOC) will investigate using Bayh-Dole march-in rights as a way to control drug …
HHS investigating using Bayh-Dole march-in rights for price controls Read More »
The Senate Commerce Committee approved legislation yesterday which prohibits pharmacy benefit managers (PBMs) from pocketing the rebates they collect from drug makers. The bill was …
Government policy impacting biotech—including drug price controls, pharmacy benefit managers (PBMs), accelerated approval, and support for new antibiotics—received a public airing this week when Health …
As Moderna CEO Stéphane Bancel heads to Capitol Hill to testify before the Health, Education, Labor, and Pensions (HELP) Committee, experts are watching to see …
To protect innovation, we need to protect Bayh-Dole, says one expert Read More »
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers Paid …
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening for …
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
Two issues critical for the biotech sector kept busy Capitol Hill on March 16: the collapse of Silicon Valley Bank (SVB) and Mexico’s biotech corn …
SVB collapse and Mexico corn ban consultations keep Capitol Hill busy Read More »
The makers of more than a dozen prescription drugs covered by Medicare are seeing the first impacts of the Inflation Reduction Act (IRA) passed last …
CMS announces penalties on 27 prescription drugs, draft guidance on price controls Read More »
